Mutation pattern in 606 Duchenne muscular dystrophy children with a comparison between familial and non-familial forms: a study in an Indian large single-center cohort.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 19 02 2019
accepted: 16 05 2019
revised: 14 05 2019
pubmed: 30 5 2019
medline: 29 1 2020
entrez: 30 5 2019
Statut: ppublish

Résumé

Duchenne muscular dystrophy (DMD) is induced by a wide spectrum of mutations such as exon deletions, duplications and small mutations in the dystrophin gene. This is the first study on the mutational spectrum in a cohort of DMD children from India, with an emphasis to compare the mutations in familial and sporadic forms. Multiplex ligation-dependent probe amplification (MLPA) and next-generation sequencing (NGS) identified 525 and 70 cases of DMD, respectively, while 11 cases showed absent dystrophin staining with no mutations detected. Families with two or more affected males contributed to 12% of the entire cohort. The mutations comprised of exonic deletions in 492/606 (81.2%), duplications in 33/606 (5.4%) and small mutations (point mutations and INDELs) in 70/606 (11.5%) cases. MLPA identified significantly more larger mutations in sporadic (88.2%) than in familial cases (75.3%). The mutations in NGS were: [nonsense = 40 (57.1%); frameshift = 17 (24.3%); splice variant = 12 (17.1%)]. Nonsense mutations were more common in familial than in sporadic cases: 17.8% vs 10.7%. The familial group reported an earlier onset of disease (2.8 ± 1.7 years) as compared to sporadic cases (3.8 ± 1.6 years). MLPA could identify mutations in a high percentage of our DMD children. The preponderance of small mutations was noted to be distinctly higher in the familial group. Intriguingly, the familial form of DMD formed a small percentage of the entire cohort. The reasons could be increasing awareness among parents and physicians with early identification of DMD cases, genetic counseling and prenatal testing.

Identifiants

pubmed: 31139960
doi: 10.1007/s00415-019-09380-3
pii: 10.1007/s00415-019-09380-3
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2177-2185

Références

Natl Med J India. 2000 May-Jun;13(3):129-31
pubmed: 11558111
Hum Genet. 2005 Jun;117(1):92-8
pubmed: 15841391
Eur J Hum Genet. 2005 Nov;13(11):1231-4
pubmed: 16030524
Muscle Nerve. 2006 Aug;34(2):135-44
pubmed: 16770791
Hum Mutat. 2008 Sep;29(9):1091-9
pubmed: 18663755
Hum Mutat. 2009 Mar;30(3):293-9
pubmed: 19156838
Hum Mutat. 2009 Jun;30(6):934-45
pubmed: 19367636
Hum Mutat. 2009 Dec;30(12):1657-66
pubmed: 19937601
Neurol India. 2009 Nov-Dec;57(6):734-8
pubmed: 20139501
J Neurol. 2011 Sep;258(9):1610-23
pubmed: 21399986
Hum Mutat. 2011 Mar;32(3):299-308
pubmed: 21972111
Indian J Hum Genet. 2012 Jan;18(1):91-4
pubmed: 22754229
J Mol Neurosci. 2013 Jun;50(2):314-6
pubmed: 23381834
BMC Med Genet. 2013 Mar 01;14:29
pubmed: 23453023
J Hum Genet. 2014 Jan;59(1):46-50
pubmed: 24225992
Am J Hum Genet. 1989 Oct;45(4):498-506
pubmed: 2491009
Neurol Clin. 2014 Aug;32(3):671-88, viii
pubmed: 25037084
Arch Dis Child. 2014 Dec;99(12):1074-7
pubmed: 25187493
Hum Mutat. 2015 Apr;36(4):395-402
pubmed: 25604253
Neurol India. 2015 Jan-Feb;63(1):58-62
pubmed: 25751470
PLoS One. 2015 Aug 18;10(8):e0135189
pubmed: 26284620
J Med Genet. 2016 Mar;53(3):145-51
pubmed: 26754139
Neurologia. 2017 Jul - Aug;32(6):377-385
pubmed: 26968818
Neuromuscul Disord. 2016 Nov;26(11):768-774
pubmed: 27666775
J Clin Neurol. 2017 Jan;13(1):91-97
pubmed: 28079318
Neuromuscul Disord. 2017 Aug;27(8):715-722
pubmed: 28318817
Lancet. 2017 Sep 23;390(10101):1489-1498
pubmed: 28728956
Orphanet J Rare Dis. 2017 Aug 31;12(1):149
pubmed: 28859693
Pediatr Neonatol. 2018 Apr;59(2):176-183
pubmed: 28903883
Neurol India. 2018 Jan-Feb;66(1):77-82
pubmed: 29322964
Curr Treat Options Neurol. 2018 Jun 23;20(8):31
pubmed: 29936551
Nat Genet. 1995 Feb;9(2):184-90
pubmed: 7719347

Auteurs

Kiran Polavarapu (K)

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.
Department of Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bangalore, India.

Veeramani Preethish-Kumar (V)

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.
Department of Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bangalore, India.

Deepha Sekar (D)

Department of Molecular Genetics, National Institute of Mental Health and Neurosciences, Bangalore, India.

Seena Vengalil (S)

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Saraswati Nashi (S)

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Niranjan P Mahajan (NP)

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Priya Treesa Thomas (PT)

Department of Psychiatric Social Work, National Institute of Mental Health and Neurosciences, Bangalore, India.

Arun Sadasivan (A)

Department of Psychiatric Social Work, National Institute of Mental Health and Neurosciences, Bangalore, India.

Manjusha Warrier (M)

Department of Psychiatric Social Work, National Institute of Mental Health and Neurosciences, Bangalore, India.

Anupam Gupta (A)

Department of Neurorehabilitation, National Institute of Mental Health and Neurosciences, Bangalore, India.

Gautham Arunachal (G)

Department of Human Genetics, National Institute of Mental Health and Neurosciences, Bangalore, India.

Monojit Debnath (M)

Department of Human Genetics, National Institute of Mental Health and Neurosciences, Bangalore, India.

Muddasu Suhasini Keerthipriya (MS)

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Chevula Pradeep-Chandra-Reddy (C)

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Arpitha Puttegowda (A)

Department of Neurophysiology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Anu P John (AP)

Department of Neurophysiology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Ajitha Tavvala (A)

Department of Neurophysiology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Swetha Gunasekaran (S)

Department of Human Genetics, National Institute of Mental Health and Neurosciences, Bangalore, India.

Talakad N Sathyaprabha (TN)

Department of Neurophysiology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Sadanandavalli Retnaswami Chandra (SR)

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Boris Kramer (B)

Department of Pediatrics, Maastricht University Medical Center, Maastricht, The Netherlands.

Tammo Delhaas (T)

Department of Biomedical Engineering, Maastricht University Medical Center, Maastricht, The Netherlands.

Atchayaram Nalini (A)

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India. atchayaramnalini@yahoo.co.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH